BARBARA B. CRABB, District Judge.
Plaintiff Agropur MSI, LLC alleges that defendant Sterling Technology, Inc. sold it colostrum powder that contained an excessive amount of gluten, in violation of the parties' contract and various warranties. On March 15, 2015, I granted plaintiff summary judgment as to liability with respect to plaintiff's claims and dismissed defendant's counterclaims on the ground that they were filed after the contractual limitations period expired. The case is set for a trial on damages on June 13, 2016. This order addresses the parties' motions in limine.
Defendant initially asserted a counterclaim related to a separate transaction between the two parties. In this counterclaim, defendant alleged that plaintiff sold it agglomerated colostrum that was contaminated with various foreign objects, such as metal shavings and warehouse beetles. I dismissed this claim in an order entered on March 15, 2016 because it was not brought within one year from the date the contamination was discovered, as was required by the parties' contract. Defendant requests that plaintiff be prohibited from making any reference to this counterclaim or its dismissal at trial. Plaintiff does not oppose defendant's motion in limine on this issue, so defendant's motion will be granted. However, as plaintiff notes, if defendant presents facts related to the dismissed counterclaim, plaintiff will be entitled to present evidence that the claim was dismissed as untimely.
Whether a party acted reasonably in attempting to mitigate its damages attributable to a breach of contract is a question of fact for a jury.
Defendant's argument for excluding the letter has no merit. The letter clearly is relevant to plaintiff's contention that its decision to delay selling the powder was reasonable. The fact that the letter's author later contradicted or clarified what she said in the letter is not grounds for excluding it; at best, her subsequent deposition testimony raises a dispute as to the scope of the hold and should be presented to a jury.
During his deposition, plaintiff's Vice-President of Quality Control, Shawn Wegner, testified that it was his belief that the gluten contamination was attributable to the drying process used by defendant. Defendant asks that plaintiff be prohibited from discussing this issue at trial because it is not relevant now that the court has found liability. Plaintiff opposes this motion because it contends that this information is relevant to rebut defendant's argument that plaintiff should have performed gluten testing immediately upon receiving the colostrum. However, as discussed later in this opinion, I am granting plaintiff's motion to exclude argument or evidence that plaintiff should have immediately conducted such testing upon receiving the colostrum. Accordingly, the basis for plaintiff's opposition to defendant's motion in limine on this issue is rendered moot and defendant's motion will be granted.
Defendant has requested that plaintiff be prohibited from making any reference to any insurance coverage that may satisfy an award of damages in this matter. I am granting this motion as unopposed. However, as plaintiff notes, if defendant suggests at trial that it may have difficulty satisfying a damages award or that a high damages award will threaten its ability to stay in business, plaintiff will be permitted to present evidence of any insurance coverage that may be available to satisfy a damages award.
Defendant has requested that plaintiff be prohibited from presenting the testimony of Mike Homewood. Defendant contends that plaintiff disclosed Homewood as a "rebuttal expert" after plaintiff had already disclosed two other "rebuttal experts" in March 2016, both of whom plaintiff deposed before Homewood was disclosed. Defendant contends that plaintiff identified Homewood as a witness only because plaintiff was displeased with the testimony of its other "rebuttal experts." However, plaintiff contends that Homewood is not a "rebuttal expert," but rather a fact witness who will testify regarding his sale of scrap food products for plaintiff on other occasions.
I am denying plaintiff's motion to exclude Homewood's testimony because the subject matter of the testimony regarding the prices Homewood was able to get for selling plaintiff's scrap food materials during the relevant time frame bears on the reasonableness of plaintiff's efforts to mitigate damages attributable to defendant's breach. The fact that plaintiff may have more than one witness capable of testifying about the prices it has received for similar scrap food materials is not a basis for excluding Homewood's testimony. Defendant does not contend that Homewood was not timely disclosed and the substance of Homewood testimony was known to defendant before the discovery cut-off. Defendant could have made arrangements to depose Homewood; its failure to do so is not a basis for excluding Homewood's testimony.
Finally, defendant's motion to exclude reference to plaintiff's vendor approval policy, dkt. #83, is moot because this policy is relevant only as evidence rebutting defendant's argument that plaintiff should have tested the colostrum immediately upon receipt. As explained in the next paragraph, plaintiff had no obligation to inspect and test the colostrum.
Plaintiff seeks to preclude defendant from arguing that defendant should not be held liable for plaintiff's damages because plaintiff should have inspected and tested the colostrum powder to ensure that it was "gluten-free" prior to mixing, packaging and sending it to its distributer for sale. I am granting this motion because plaintiff was not required to inspect the colostrum to ensure it was gluten-free prior to using it and defendant's suggestion that the duty to mitigate includes such an onerous testing or inspection requirement is not supported by the law.
No duty of inspection fell on plaintiff because defendant had expressly warranted that the product was gluten-free. Under Wisconsin law, when a seller expressly warrants that a product satisfies some condition, the buyer is under no obligation to conduct an inspection to determine whether that condition is satisfied in fact; instead, the buyer is free to rely on the warranty of the seller.
In many respects, the facts of the this case and the arguments set forth by the parties bear a strong resemblance to those before the court in
Accordingly, I am granting plaintiff's motion in limine to exclude evidence and argument regarding the need for testing prior to discovery of breach. Dkt. #101. I am also granting plaintiff's motion to exclude the testimony of Kelly Black, dkt. #100, to the extent she intends to testify regarding plaintiff's alleged obligation to inspect and test component ingredients upon receipt.
In opposition to defendant's contentions that plaintiff's duty to mitigate required it to sell the protein powder in March or April 2014, and that had it done so, it would have received approximately $4.00 per pound rather than the 70 cents it ultimately received, plaintiff has moved to exclude all evidence of the price of the powder prior to August 2015. Plaintiff contends that up until that point, it had a legal obligation to preserve the protein powder for litigation purposes. However, the reasonableness of plaintiff's decision to delay selling the product and whether the duty to preserve evidence prevented it from selling all of the product are disputed issues that must be resolved at trial. Accordingly, I am denying plaintiff's motion to exclude evidence related to the sale price of the powder before plaintiff had affirmative permission to sell from defendant.
Plaintiff also moves to exclude the following testimony offered by defendant's expert, Drew Vermeire: (1) Vermeire's opinion regarding the price of the protein product in March and April 2014; (2) Vermeire's opinion that plaintiff should have sold the protein product immediately after discovering it was contaminated; and (3) Vermeire's "commercial reasonableness" opinion. Again, plaintiff contends that this testimony is rendered irrelevant by the fact that plaintiff was under a litigation hold that prevented it from selling the protein powder prior to August 2015. However, as discussed above, the existence of this hold and whether it rendered plaintiff's delay in selling reasonable are disputed issues.
Plaintiff also requests that Vermeire's opinion regarding the April 2014 price data be excluded as "improper supplementation." I am denying this request because Vermeire needed to supplement his report to include the April 2014 price data after defendant learned that it took plaintiff a month to broker a sale of the protein powder. When Vermeire issued his original report, he was not aware of the fact that plaintiff was incapable of selling the protein immediately. It was only after he learned of the delay that he decided to supplement his report. This supplemental opinion was disclosed more than a week before Vermeire's deposition and plaintiff had a full opportunity to question him about the price data set forth in the report. Accordingly, I am denying plaintiff's motion to exclude Vermeire's opinion regarding the April 2014 price data.
However, I am granting plaintiff's motion to exclude Vermeire's opinions regarding the commercial reasonableness of holding the powder, the need to immediately sell the powder and how the powder might lose value due to the "Maillard reaction." Although all of these matters relate to the allegedly proper storage and disposition of food ingredients, Vermeire did not discuss any of these opinions in his initial report, which dealt exclusively with calculating the resale price of the protein powder. Defendant fails to offer any explanation for why Vermeire did not disclose his opinions with respect to these issues in his original report and fails to explain how they might qualify as proper supplementation under Rule 26(e).
IT IS ORDERED that
1. Defendant Sterling Technology, Inc.'s motion to exclude any reference to the fact that defendant's counterclaim was dismissed, dkt. #83 at 4, is GRANTED.
2. Defendant's motion to exclude reference to plaintiff's "vendor approval policy," dkt. #83 at 6, is denied as MOOT.
3. Defendant's motion to exclude reference to Lockner's March 12, 2015 hold letter, dkt. #83 at 7, is DENIED.
4. Defendant's motion to exclude reference to the cause of the colostrum contamination, dkt. #83 at 5, 10, is GRANTED.
5. Defendant's motion to exclude reference to defendant's insurance coverage, dkt. #83, 11, is GRANTED.
6. Defendant's motion to exclude the testimony of Mike Homewood, dkt. #83 at 12, is DENIED.
7. Plaintiff Agropur MSI, LLC's motion to exclude evidence and argument regarding testing prior to the discovery of the breach, dkt. #101, is GRANTED.
8. Plaintiff Agropur MSI, LLC's motion to exclude the testimony of Kelly Black, dkt. #99, is GRANTED.
9. Plaintiff's motion to exclude evidence of sales price before plaintiff had permission to sell, dkt. #109, is DENIED.
10. Plaintiff's motion to exclude the testimony of Drew Vermeire, dkt. #97, is GRANTED in part and DENIED in part. Vermeire will be allowed to testify about the sale price of the protein powder in March and April of 2014. However, Vermeire will not be allowed to testify about the matters described in paragraph 2 of his supplemental report or the "commercial reasonableness" of plaintiff's delay.